[ Price : $8.95]
A new poll finds public confidence in FDA and Centers for Disease Control and Prevention remains low following recent changes to t...[ Price : $8.95]
FDA cites Ipca Laboratories over multiple manufacturing and quality deficiencies following an inspection of the companys active ph...[ Price : $8.95]
A new spending package enacted this week includes two long-sought policy changes for FDA clarifying the scope of orphan drug excl...[ Price : $8.95]
FDA publishes for public comment an International Council for Harmonization draft guideline on patient preference studies involvin...[ Price : $8.95]
Sangamo Therapeutics begins a rolling BLA submission seeking accelerated approval of its experimental Fabry disease gene therapy, ...[ Price : $8.95]
Bayer reports that its investigational oral anticoagulant asundexian reduced the risk of recurrent ischemic stroke by 26% in patie...[ Price : $8.95]
A PDUFA 8 negotiating subgroup reviews industrys counterproposal to FDAs facility lifecycle proposal.[ Price : $8.95]
Reuters reports exclusively that the telehealth firm Hims and Hers Health is selling GLP-1 pills for $100 less per month than the ...